Standard

Итоги междисциплинарного международного экспертного совета по решению проблем ведения пациентов с неалкогольной (метаболически ассоциированной) жировой болезнью печени. / Maevskaya, M. V.; Okovityi, S. V.; Bakulin, I. G.; Bidzhiev, A. S.; Glushenkov, D. V.; Gurova, O. Yu.; Gorshkov, A. Yu.; Zhakipbekova, V. A.; Zolnikova, O. Yu.; Karimov, M. M.; Kotovskaya, Yu. V.; Maev, I. V.; Maslennikov, R. V.; Nadinskaia, M. Yu.; Osipenko, M. F.; Raikhelson, K. L.; Sultanova, B. P.; Tkacheva, O. N.; Troshina, E. A.; Khalimova, Z. Yu.; Khamidullaeva, G. A.; Sheptulina, A. F.; Shirokova, E. N.; Drapkina, O. M.; Ivashkin, V. T.

в: РОССИЙСКИЙ ЖУРНАЛ ГАСТРОЭНТЕРОЛОГИИ, ГЕПАТОЛОГИИ, КОЛОПРОКТОЛОГИИ, Том 36, № 3, 30.06.2026, стр. 7-20.

Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование

Harvard

Maevskaya, MV, Okovityi, SV, Bakulin, IG, Bidzhiev, AS, Glushenkov, DV, Gurova, OY, Gorshkov, AY, Zhakipbekova, VA, Zolnikova, OY, Karimov, MM, Kotovskaya, YV, Maev, IV, Maslennikov, RV, Nadinskaia, MY, Osipenko, MF, Raikhelson, KL, Sultanova, BP, Tkacheva, ON, Troshina, EA, Khalimova, ZY, Khamidullaeva, GA, Sheptulina, AF, Shirokova, EN, Drapkina, OM & Ivashkin, VT 2026, 'Итоги междисциплинарного международного экспертного совета по решению проблем ведения пациентов с неалкогольной (метаболически ассоциированной) жировой болезнью печени', РОССИЙСКИЙ ЖУРНАЛ ГАСТРОЭНТЕРОЛОГИИ, ГЕПАТОЛОГИИ, КОЛОПРОКТОЛОГИИ, Том. 36, № 3, стр. 7-20. https://doi.org/10.22416/1382-4376-2026-36-3-7-20, https://doi.org/10.22416/1382-4376-2026-36-3-7-20

APA

Maevskaya, M. V., Okovityi, S. V., Bakulin, I. G., Bidzhiev, A. S., Glushenkov, D. V., Gurova, O. Y., Gorshkov, A. Y., Zhakipbekova, V. A., Zolnikova, O. Y., Karimov, M. M., Kotovskaya, Y. V., Maev, I. V., Maslennikov, R. V., Nadinskaia, M. Y., Osipenko, M. F., Raikhelson, K. L., Sultanova, B. P., Tkacheva, O. N., Troshina, E. A., ... Ivashkin, V. T. (2026). Итоги междисциплинарного международного экспертного совета по решению проблем ведения пациентов с неалкогольной (метаболически ассоциированной) жировой болезнью печени. РОССИЙСКИЙ ЖУРНАЛ ГАСТРОЭНТЕРОЛОГИИ, ГЕПАТОЛОГИИ, КОЛОПРОКТОЛОГИИ, 36(3), 7-20. https://doi.org/10.22416/1382-4376-2026-36-3-7-20, https://doi.org/10.22416/1382-4376-2026-36-3-7-20

Vancouver

Maevskaya MV, Okovityi SV, Bakulin IG, Bidzhiev AS, Glushenkov DV, Gurova OY и пр. Итоги междисциплинарного международного экспертного совета по решению проблем ведения пациентов с неалкогольной (метаболически ассоциированной) жировой болезнью печени. РОССИЙСКИЙ ЖУРНАЛ ГАСТРОЭНТЕРОЛОГИИ, ГЕПАТОЛОГИИ, КОЛОПРОКТОЛОГИИ. 2026 Июнь 30;36(3):7-20. https://doi.org/10.22416/1382-4376-2026-36-3-7-20, https://doi.org/10.22416/1382-4376-2026-36-3-7-20

Author

Maevskaya, M. V. ; Okovityi, S. V. ; Bakulin, I. G. ; Bidzhiev, A. S. ; Glushenkov, D. V. ; Gurova, O. Yu. ; Gorshkov, A. Yu. ; Zhakipbekova, V. A. ; Zolnikova, O. Yu. ; Karimov, M. M. ; Kotovskaya, Yu. V. ; Maev, I. V. ; Maslennikov, R. V. ; Nadinskaia, M. Yu. ; Osipenko, M. F. ; Raikhelson, K. L. ; Sultanova, B. P. ; Tkacheva, O. N. ; Troshina, E. A. ; Khalimova, Z. Yu. ; Khamidullaeva, G. A. ; Sheptulina, A. F. ; Shirokova, E. N. ; Drapkina, O. M. ; Ivashkin, V. T. / Итоги междисциплинарного международного экспертного совета по решению проблем ведения пациентов с неалкогольной (метаболически ассоциированной) жировой болезнью печени. в: РОССИЙСКИЙ ЖУРНАЛ ГАСТРОЭНТЕРОЛОГИИ, ГЕПАТОЛОГИИ, КОЛОПРОКТОЛОГИИ. 2026 ; Том 36, № 3. стр. 7-20.

BibTeX

@article{cd2f8d6a3d584078b940f463e471010b,
title = "Итоги междисциплинарного международного экспертного совета по решению проблем ведения пациентов с неалкогольной (метаболически ассоциированной) жировой болезнью печени",
abstract = "Aim: to present the results of an interdisciplinary international expert council on addressing the challenges of managing patients with non-alcoholic (metabolic dysfunction-associated) fatty liver disease in connection with the creation of a new nomenclature, the definition of diagnostic criteria, and the development of approaches to the diagnosis and treatment of fatty liver disease. Key points. The key role of metabolic dysfunction in non-alcoholic (metabolic dysfunction-associated) fatty liver disease has been proven. Therefore, in the nomenclature, non-alcoholic fatty liver disease (NAFLD) has been replaced by metabolic dysfunction-associated fatty liver disease, and non-alcoholic steatohepatitis has been replaced by metabolic dysfunction-associated steatohepatitis. It is noted that, according to research, the prevalence of fatty liver disease in Russia is high: one-third of patients seeking primary care have this diagnosis. The results of a study of two incretin mimetics, semaglutide and tirzepatide, are presented, along with an opinion on their rational combination with ursodeoxycholic acid. The comorbidity of fatty liver disease with cardiovascular, endocrine, and oncological diseases, chronic kidney disease, and other conditions is discussed. Conclusion. The expert council included leading specialists: gastroenterologists-hepatologists, cardiologists, internists, and endocrinologists. There were confirmed that treatment for fatty liver disease should be comprehensive and integrated into the overall concept of metabolic health. Algorithms for diagnosis and personalized treatment of fatty liver disease have to be developed for the Russian medical community.",
author = "Maevskaya, {M. V.} and Okovityi, {S. V.} and Bakulin, {I. G.} and Bidzhiev, {A. S.} and Glushenkov, {D. V.} and Gurova, {O. Yu.} and Gorshkov, {A. Yu.} and Zhakipbekova, {V. A.} and Zolnikova, {O. Yu.} and Karimov, {M. M.} and Kotovskaya, {Yu. V.} and Maev, {I. V.} and Maslennikov, {R. V.} and Nadinskaia, {M. Yu.} and Osipenko, {M. F.} and Raikhelson, {K. L.} and Sultanova, {B. P.} and Tkacheva, {O. N.} and Troshina, {E. A.} and Khalimova, {Z. Yu.} and Khamidullaeva, {G. A.} and Sheptulina, {A. F.} and Shirokova, {E. N.} and Drapkina, {O. M.} and Ivashkin, {V. T.}",
note = "Маевская М.В., Оковитый С.В., Бакулин И.Г., Биджиев А.С., Глушенков Д.В., Гурова О.Ю., Горшков А.Ю., Жакипбекова В.А., Зольникова О.Ю., Каримов М.М., Котовская Ю.В., Маев И.В., Масленников Р.В., Надинская М.Ю., Осипенко М.Ф., Райхельсон К.Л., Султанова Б.П., Ткачева О.Н., Трошина Е.А., Халимова З.Ю., Хамидуллаева Г.А., Шептулина А.Ф., Широкова Е.Н., Драпкина О.М., Ивашкин В.Т. Итоги междисциплинарного международного экспертного совета по решению проблем ведения пациентов с неалкогольной (метаболически ассоциированной) жировой болезнью печени. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2026;36(3):7-20. https://doi.org/10.22416/1382-4376-2026-36-3-7-20 For citation:",
year = "2026",
month = jun,
day = "30",
doi = "10.22416/1382-4376-2026-36-3-7-20",
language = "русский",
volume = "36",
pages = "7--20",
journal = "РОССИЙСКИЙ ЖУРНАЛ ГАСТРОЭНТЕРОЛОГИИ, ГЕПАТОЛОГИИ, КОЛОПРОКТОЛОГИИ",
issn = "1382-4376",
publisher = "Гастро",
number = "3",

}

RIS

TY - JOUR

T1 - Итоги междисциплинарного международного экспертного совета по решению проблем ведения пациентов с неалкогольной (метаболически ассоциированной) жировой болезнью печени

AU - Maevskaya, M. V.

AU - Okovityi, S. V.

AU - Bakulin, I. G.

AU - Bidzhiev, A. S.

AU - Glushenkov, D. V.

AU - Gurova, O. Yu.

AU - Gorshkov, A. Yu.

AU - Zhakipbekova, V. A.

AU - Zolnikova, O. Yu.

AU - Karimov, M. M.

AU - Kotovskaya, Yu. V.

AU - Maev, I. V.

AU - Maslennikov, R. V.

AU - Nadinskaia, M. Yu.

AU - Osipenko, M. F.

AU - Raikhelson, K. L.

AU - Sultanova, B. P.

AU - Tkacheva, O. N.

AU - Troshina, E. A.

AU - Khalimova, Z. Yu.

AU - Khamidullaeva, G. A.

AU - Sheptulina, A. F.

AU - Shirokova, E. N.

AU - Drapkina, O. M.

AU - Ivashkin, V. T.

N1 - Маевская М.В., Оковитый С.В., Бакулин И.Г., Биджиев А.С., Глушенков Д.В., Гурова О.Ю., Горшков А.Ю., Жакипбекова В.А., Зольникова О.Ю., Каримов М.М., Котовская Ю.В., Маев И.В., Масленников Р.В., Надинская М.Ю., Осипенко М.Ф., Райхельсон К.Л., Султанова Б.П., Ткачева О.Н., Трошина Е.А., Халимова З.Ю., Хамидуллаева Г.А., Шептулина А.Ф., Широкова Е.Н., Драпкина О.М., Ивашкин В.Т. Итоги междисциплинарного международного экспертного совета по решению проблем ведения пациентов с неалкогольной (метаболически ассоциированной) жировой болезнью печени. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2026;36(3):7-20. https://doi.org/10.22416/1382-4376-2026-36-3-7-20 For citation:

PY - 2026/6/30

Y1 - 2026/6/30

N2 - Aim: to present the results of an interdisciplinary international expert council on addressing the challenges of managing patients with non-alcoholic (metabolic dysfunction-associated) fatty liver disease in connection with the creation of a new nomenclature, the definition of diagnostic criteria, and the development of approaches to the diagnosis and treatment of fatty liver disease. Key points. The key role of metabolic dysfunction in non-alcoholic (metabolic dysfunction-associated) fatty liver disease has been proven. Therefore, in the nomenclature, non-alcoholic fatty liver disease (NAFLD) has been replaced by metabolic dysfunction-associated fatty liver disease, and non-alcoholic steatohepatitis has been replaced by metabolic dysfunction-associated steatohepatitis. It is noted that, according to research, the prevalence of fatty liver disease in Russia is high: one-third of patients seeking primary care have this diagnosis. The results of a study of two incretin mimetics, semaglutide and tirzepatide, are presented, along with an opinion on their rational combination with ursodeoxycholic acid. The comorbidity of fatty liver disease with cardiovascular, endocrine, and oncological diseases, chronic kidney disease, and other conditions is discussed. Conclusion. The expert council included leading specialists: gastroenterologists-hepatologists, cardiologists, internists, and endocrinologists. There were confirmed that treatment for fatty liver disease should be comprehensive and integrated into the overall concept of metabolic health. Algorithms for diagnosis and personalized treatment of fatty liver disease have to be developed for the Russian medical community.

AB - Aim: to present the results of an interdisciplinary international expert council on addressing the challenges of managing patients with non-alcoholic (metabolic dysfunction-associated) fatty liver disease in connection with the creation of a new nomenclature, the definition of diagnostic criteria, and the development of approaches to the diagnosis and treatment of fatty liver disease. Key points. The key role of metabolic dysfunction in non-alcoholic (metabolic dysfunction-associated) fatty liver disease has been proven. Therefore, in the nomenclature, non-alcoholic fatty liver disease (NAFLD) has been replaced by metabolic dysfunction-associated fatty liver disease, and non-alcoholic steatohepatitis has been replaced by metabolic dysfunction-associated steatohepatitis. It is noted that, according to research, the prevalence of fatty liver disease in Russia is high: one-third of patients seeking primary care have this diagnosis. The results of a study of two incretin mimetics, semaglutide and tirzepatide, are presented, along with an opinion on their rational combination with ursodeoxycholic acid. The comorbidity of fatty liver disease with cardiovascular, endocrine, and oncological diseases, chronic kidney disease, and other conditions is discussed. Conclusion. The expert council included leading specialists: gastroenterologists-hepatologists, cardiologists, internists, and endocrinologists. There were confirmed that treatment for fatty liver disease should be comprehensive and integrated into the overall concept of metabolic health. Algorithms for diagnosis and personalized treatment of fatty liver disease have to be developed for the Russian medical community.

UR - https://www.mendeley.com/catalogue/2a9e61b5-7ea8-3059-8e54-722726664803/

U2 - 10.22416/1382-4376-2026-36-3-7-20

DO - 10.22416/1382-4376-2026-36-3-7-20

M3 - статья

VL - 36

SP - 7

EP - 20

JO - РОССИЙСКИЙ ЖУРНАЛ ГАСТРОЭНТЕРОЛОГИИ, ГЕПАТОЛОГИИ, КОЛОПРОКТОЛОГИИ

JF - РОССИЙСКИЙ ЖУРНАЛ ГАСТРОЭНТЕРОЛОГИИ, ГЕПАТОЛОГИИ, КОЛОПРОКТОЛОГИИ

SN - 1382-4376

IS - 3

ER -

ID: 156847544